Publication date: November 2023
Source: Biochemical Pharmacology, Volume 217
Author(s): Jingqian Su, Lu Tang, Yingsheng Luo, Jingran Xu, Songying Ouyang
Clinical physiology and pharmacology of GSTZ1/MAAI
Publication date: November 2023
Source: Biochemical Pharmacology, Volume 217
Author(s): Peter W. Stacpoole
Unraveling the interplay between RAS/RAF/MEK/ERK signaling pathway and autophagy in cancer: From molecular mechanisms to targeted therapy
Publication date: November 2023
Source: Biochemical Pharmacology, Volume 217
Author(s): Yunli Huang, Yongqi Zhen, Yanmei Chen, Shaoguang Sui, Lan Zhang
NAP1L5 facilitates pancreatic ductal adenocarcinoma progression via TRIM29-mediated ubiquitination of PHLPP1
Publication date: November 2023
Source: Biochemical Pharmacology, Volume 217
Author(s): Benli Xiao, Yuzhen Ge, Rui Zhao, Yewei Zhang, Yi Guo, Shilong Zhang, Bo Li, Peng Qiu, Zheng Chao, Shi Zuo
Cucurbitacin C suppresses the progression of pancreatic ductal adenocarcinoma via inhibition of the cGMP-PKG-VASP axis
Publication date: November 2023
Source: Biochemical Pharmacology, Volume 217
Author(s): Dongchao Xu, Ajuan Liu, Qiang Liu, Hongchen Zhang, Mengyao Tian, Ying Bian, Xiaofeng Zhang, Meidan Ying, Hongzhang Shen
Scutellarin suppresses the metastasis of triple-negative breast cancer via targeting TNF<em>α</em>/TNFR2-RUNX1-triggered G-CSF expression in endothelial cells
Publication date: November 2023
Source: Biochemical Pharmacology, Volume 217
Author(s): Xiyu Mei, Hao Ouyang, Hong Zhang, Wangya Jia, Bin Lu, Jingnan Zhang, Lili Ji
Ayanin, a natural flavonoid inhibitor of Caseinolytic protease, is a promising therapeutic agent to combat methicillin-resistant <em>Staphylococcus aureus</em> infections
Publication date: November 2023
Source: Biochemical Pharmacology, Volume 217
Author(s): Mengli Jin, Shuyue Zhu, Yating Tang, Xiangri Kong, Xingye Wang, Yufen Li, Shuang Jiang, Lin Wei, Chunjie Hu, Bingmei Wang, Wu Song
Lycorine inhibits pancreatic cancer cell growth and neovascularization by inducing Notch1 degradation and downregulating key vasculogenic genes
Publication date: November 2023
Source: Biochemical Pharmacology, Volume 217
Author(s): Jindan Qi, Mei Meng, Juntao Liu, Xiaoxiao Song, Yu Chen, Yuxi Liu, Xu Li, Zhou Zhou, Xiang Huang, Xiaohua Wang, Quansheng Zhou, Zhe Zhao
Dauricine regulates prostate cancer progression by inhibiting PI3K/AKT-dependent M2 polarization of macrophages
Publication date: November 2023
Source: Biochemical Pharmacology, Volume 217
Author(s): Mengxuan Li, Nan Che, Xingzhe Liu, Yanhua Xuan, Yu Jin
Regression of ovarian cancer xenografts by depleting or inhibiting RLIP
Publication date: November 2023
Source: Biochemical Pharmacology, Volume 217
Author(s): Sravani K. Ramisetty, Pankaj Garg, Atish Mohanty, Tamara Mirzapoiazova, Er Yue, Edward Wang, David Horne, Sanjay Awasthi, Prakash Kulkarni, Ravi Salgia, Sharad S. Singhal